Clinical Trials

Diarrhea Prevention and Prophylaxis with Crofelemer in HER2 Positive Breast Cancer Patients Receiving Trastuzumab, Pertuzumab, and Docetaxel or Paclitaxel with or without Carboplatin


Study ID
Georgetown 2015-0547 HALT-D

NCT Number
NCT02910219 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0495

Principle Investigator
Dr. Deena Graham

Phase
II

Sponsor
Georgetown University


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now